Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma
ClinicalTrials.gov study NCT06988020. IPD Sharing: NO. Countries: 1. Publications: 3.
Connect® MM- The Multiple Myeloma Disease Registry
ClinicalTrials.gov study NCT01081028. IPD Sharing: Not stated. Countries: 2. Publications: 16.
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02278315. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
ClinicalTrials.gov study NCT04850846. IPD Sharing: YES. Countries: 1. Publications: 0.
Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001)
ClinicalTrials.gov study NCT00701103. IPD Sharing: YES. Countries: 0. Publications: 1.
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
ClinicalTrials.gov study NCT04322292. IPD Sharing: NO. Countries: 1. Publications: 1.
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
ClinicalTrials.gov study NCT02559583. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy an
ClinicalTrials.gov study NCT02918331. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bone Pain in Multiple Myeloma- a Translational Study
ClinicalTrials.gov study NCT04273425. IPD Sharing: NO. Countries: 1. Publications: 1.
T Cells Expressing a Bispecific CAR Targeting CS1 and BCMA in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04662099. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomo
ClinicalTrials.gov study NCT04035226. IPD Sharing: NO. Countries: 10. Publications: 7.
Selinexor and Backbone Treatments of Multiple Myeloma Patients
ClinicalTrials.gov study NCT02343042. IPD Sharing: UNDECIDED. Countries: 2. Publications: 3.
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
ClinicalTrials.gov study NCT04295018. IPD Sharing: NO. Countries: 1. Publications: 1.
BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT03070327. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02519452. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
ClinicalTrials.gov study NCT00116961. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
ClinicalTrials.gov study NCT00003954. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
ClinicalTrials.gov study NCT04822337. IPD Sharing: NO. Countries: 1. Publications: 0.
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01665794. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
ClinicalTrials.gov study NCT04533217. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.